How to use... neonatal TORCH testing

Archives of Disease in Childhood: Education and Practice Edition

Volumn 98, Issue 3, 2013, Pages 93-98

  De Jong, Eveline P ^a   Vossen, Ann C T M ^b   Walther, Frans J ^b   Lopriore, Enrico ^b  

^a HAGA HOSPITAL   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

CESAREAN SECTION; CONGENITAL RUBELLA SYNDROME; CONGENITAL TOXOPLASMOSIS; CYTOMEGALOVIRUS INFECTION; DNA EXTRACTION; FIRST TRIMESTER PREGNANCY; GOLD STANDARD; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; MENINGOENCEPHALITIS; MOLECULAR DIAGNOSIS; NEWBORN SCREENING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; REVIEW; SEROLOGY; SEROPREVALENCE; SMALL FOR DATE INFANT; ULTRASOUND; VERTICAL TRANSMISSION; VIRUS SHEDDING; WESTERN BLOTTING;

FETAL MEDICINE; INFECTIOUS DISEASES; NEONATOLOGY; VIROLOGY;

CYTOMEGALOVIRUS INFECTIONS; HERPES SIMPLEX; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; NEONATAL SCREENING; RUBELLA; TOXOPLASMOSIS, CONGENITAL;

EID: 84878301702     PISSN: 17430585     EISSN: 17430593     Source Type: Journal    
DOI: 10.1136/archdischild-2012-303327     Document Type: Review

References (120)

1. Nahmias AJ, Walls KW, Steward J, et al. The ToRCH complex-perinatal infections associated with toxoplasma and rubella, cytomegalo- and herpes simplex viruses. Pediatr Res 1971;5:405-6.
2. Tolan RWJ. Passing the "TORCH". Infec Dis Clin Prac 2008;16:4-5.
3. de Jong EP, Lopriore E, Vossen AC, et al. Is routine TORCH screening warranted in neonates with lenticulostriate vasculopathy? Neonatology 2010;97:274-8.
4. van der Weiden S, de Jong EP, Te Pas AB, et al. Is routine TORCH screening and urine CMV culture warranted in small for gestational age neonates? Early Hum Dev 2011;87:103-7.
5. van der Weiden S, Steggerda SJ, Te Pas AB, et al. Routine TORCH screening is not warranted in neonates with subependymal cysts. Early Hum Dev 2010;86:203-7.
6. Abdel-Fattah SA, Bhat A, Illanes S, et al. TORCH test for fetal medicine indications: only CMV is necessary in the United Kingdom. Prenat Diagn 2005;25:1028-31. (Pubitemid 41745682)
7. Khan NA, Kazzi SN. Yield and costs of screening growth-retarded infants for torch infections. Am J Perinatol 2000;17:131-5.
8. Yamamoto R, Ishii K, Shimada M, et al. Significance of maternal screening for toxoplasmosis, rubella, cytomegalovirus and herpes simplex virus infection in cases of fetal growth restriction. J Obstet Gynaecol Res 2013;39:653-7.
9. Jones JL, Dargelas V, Roberts J, et al. Risk factors for toxoplasma gondii infection in the United States. Clin Infect Dis 2009;49:878-84.
10. Cook AJ, Gilbert RE, Buffolano W, et al. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ 2000;321:142-7. (Pubitemid 30447005)
11. Onadeko MO, Joynson DH, Payne RA, et al. The prevalence of toxoplasma antibodies in pregnant Nigerian women and the occurrence of stillbirth and congenital malformation. Afr J Med Med Sci 1996;25:331-4.
12. Goldenberg RL, Thompson C. The infectious origins of stillbirth. Am J Obstet Gynecol 2003;189:861-73. (Pubitemid 37194123)
13. Foulon W, Villena I, Stray-Pedersen B, et al. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol 1999;180:410-15. (Pubitemid 29093877)
14. Benard A, Petersen E, Salamon R, et al. Survey of European programmes for the epidemiological surveillance of congenital toxoplasmosis. Euro Surveill 2008;13:18834.
15. Dunn D, Wallon M, Peyron F, et al. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 1999;353:1829-33. (Pubitemid 29251014)
16. Villena I, Ancelle T, Delmas C, et al. Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Euro Surveill 2010;15:19600.
17. Remington JS, Klein JO, Wilson CB, et al. Infectious diseases of the fetus and newborn. 7th edn. Philadelphia, USA: Elsevier Saunders, 2007.
18. Freeman K, Salt A, Prusa A, et al. Association between congenital toxoplasmosis and parent-reported developmental outcomes, concerns, and impairments, in 3-year-old children. BMC Pediatr 2005;5:23.
19. Gras L, Wallon M, Pollak A, et al. Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres. Acta Paediatr 2005;94:1721-31. (Pubitemid 43155582)
20. Hoekstra F, Buzing C, Sporken JM, et al. Congenital toxoplasmosis: severe ocular and neurological complications. Ned Tijdschr Geneeskd 2011;155:A2853.
21. de Vries LS, Verboon-Maciolek MA, Cowan FM, et al. The role of cranial ultrasound and magnetic resonance imaging in the diagnosis of infections of the central nervous system. Early Hum Dev 2006;82:819-25. (Pubitemid 44692403)
22. Tan HK, Schmidt D, Stanford M, et al. Risk of visual impairment in children with congenital toxoplasmic retinochoroiditis. Am J Ophthalmol 2007;144:648-53.
23. Cortina-Borja M, Tan HK, Wallon M, et al. Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study. PLoS Med 2010;7. Published Online First: 23 October 2010. doi:e1000351 [pii] 10.1371/journal.pmed.1000351
24. Lee JY, Bowden DS. Rubella virus replication and links to teratogenicity. Clin Microbiol Rev 2000;13:571-87.
25. http://www.who.int/immunization-monitoring/diseases/rubella/en/index.html 01-02-2012 (accessed 1 Feb 2012).
26. Miller E, Cradock-Watson JE, Pollock TM. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet 1982;2:781-4. (Pubitemid 12068990)
27. Gregg NM. Congenital cataract following German measles in the mother. Trans Ophthalmol Soc Aust 1941;3:35.
28. Best JM. Rubella. Semin Fetal Neonatal Med 2007;12:182-92. (Pubitemid 46670819)
29. Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 2007;17:355-63. (Pubitemid 47425872)
30. Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007;17:253-76. (Pubitemid 47066638)
31. Tian C, Ali SA, Weitkamp J. Congenital infections, part 1: cytomegalovirus, toxoplasma, rubella and herpes simplex. NeoReviews 2010;11:e436-46.
32. Boppana SB, Rivera LB, Fowler KB, et al. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 2001;344:1366-71. (Pubitemid 32378391)
33. Malm G, Engman ML. Congenital cytomegalovirus infections. Semin Fetal Neonatal Med 2007;12:154-9. (Pubitemid 46670816)
34. Sauerbrei A, Schmitt S, Scheper T, et al. Seroprevalence of herpes simplex virus type 1 and type 2 in Thuringia, Germany, 1999 to 2006. Euro Surveill 2011;16:20005.
35. Wentworth BB, Alexander ER. Seroepidemiology of infectious due to members of the herpesvirus group. Am J Epidemiol 1971;94:496-507.
36. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 2002;186(Suppl 1):S3-28.
37. Prober CG, Sullender WM, Yasukawa LL, et al. Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections. N Engl J Med 1987;316:240-4. (Pubitemid 17051049)
38. Brown ZA, Wald A, Morrow RA, et al. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003;289:203-9. (Pubitemid 36068708)
39. Poeran J, Wildschut H, Gaytant M, et al. The incidence of neonatal herpes in The Netherlands. J Clin Virol 2008;42:321-25.
40. Tookey P, Peckham CS. Neonatal herpes simplex virus infection in the British Isles. Paediatr Perinat Epidemiol 1996;10:432-42. (Pubitemid 26366435)
41. Hartup C, Johnson JD, Holliman RE. Toxoplasma and pregnancy. Lancet 1991;338:317-18.
42. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004;363:1965-76. (Pubitemid 38759657)
43. Pinon JM, Dumon H, Chemla C, et al. Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J Clin Microbiol 2001;39:2267-71. (Pubitemid 32531492)
44. Sterkers Y, Ribot J, Albaba S, et al. Diagnosis of congenital toxoplasmosis by polymerase chain reaction on neonatal peripheral blood. Diagn Microbiol Infect Dis 2011;71:174-6.
45. Revello MG, Baldanti F, Sarasini A, et al. Prenatal diagnosis of rubella virus infection by direct detection and semiquantitation of viral RNA in clinical samples by reverse transcription-PCR. J Clin Microbiol 1997;35:708-13. (Pubitemid 27083866)
46. Okamoto K, Fujii K, Komase K. Development of a novel TaqMan real-time PCR assay for detecting rubella virus RNA. J Virol Methods 2010;168:267-71.
47. Abernathy E, Cabezas C, Sun H, et al. Confirmation of rubella within 4 days of rash onset: comparison of rubella virus RNA detection in oral fluid with immunoglobulin M detection in serum or oral fluid. J Clin Microbiol 2009;47:182-8.
48. Schlesinger Y, Halle D, Eidelman AI, et al. Urine polymerase chain reaction as a screening tool for the detection of congenital cytomegalovirus infection. Arch Dis Child Fetal Neonatal Ed 2003;88:F371-4. (Pubitemid 37094253)
49. Stagno S, Tinker MK, Elrod C, et al. Immunoglobulin M antibodies detected by enzyme-linked immunosorbent assay and radioimmunoassay in the diagnosis of cytomegalovirus infections in pregnant women and newborn infants. J Clin Microbiol 1985;21:930-5. (Pubitemid 15058941)
50. de Vries JJ, Claas EC, Kroes AC, et al. Evaluation of DNA extraction methods for dried blood spots in the diagnosis of congenital cytomegalovirus infection. J Clin Virol 2009;46(Suppl 4):S37-42.
51. Boppana SB, Ross SA, Novak Z, et al. Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection. JAMA 2010;303:1375-82.
52. de Vries JJ, Wessels E, Korver AM, et al. Rapid genotyping of cytomegalovirus in dried blood spots by multiplex real-time PCR assays targeting the envelope glycoprotein gB and gH genes. J Clin Microbiol 2012;50:232-7.
53. de Vries JJ, Vossen AC, Kroes AC. Screening newborns for congenital cytomegalovirus infection. JAMA 2010;304:407.
54. Lazzarotto T, Guerra B, Lanari M, et al. New advances in the diagnosis of congenital cytomegalovirus infection. J Clin Virol 2008;41:192-7. (Pubitemid 351246738)
55. Whitley RJ, Lakeman F. Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations. Clin Infect Dis 1995;20:414-20.
56. Kimura H, Futamura M, Kito H, et al. Detection of viral DNA in neonatal herpes simplex virus infections: frequent and prolonged presence in serum and cerebrospinal fluid. J Infect Dis 1991;164:289-93.
57. Battaglia FC, Lubchenco LO. A practical classification of newborn infants by weight and gestational age. J Pediatr 1967;71:159-63.
58. Gardosi J, Chang A, Kalyan B, et al. Customised antenatal growth charts. Lancet 1992;339:283-7.
59. Vandenbosche RC, Kirchner JT. Intrauterine growth retardation. Am Fam Physician 1998;58:1384-90, 93-4.
60. Primhak RA, Simpson RM. Screening small for gestational age babies for congenital infection. Clin Pediatr (Phila) 1982;21:417-20. (Pubitemid 12050201)
61. Al-Hareth Z, Monem F, Megiud N Abdel. Is low birth weight a risk indicator for congenital cytomegalovirus infection? J Infect Dev Ctries 2010;4:44-7.
62. Freeman K, Oakley L, Pollak A, et al. Association between congenital toxoplasmosis and preterm birth, low birthweight and small for gestational age birth. BJOG 2005;112:31-7. (Pubitemid 40095077)
63. Couvreur J, Desmonts G. Congenital and maternal toxoplasmosis. A review of 300 congenital cases. Dev Med Child Neurol 1962;4:519-30.
64. Lago EG, Baldisserotto M, Hoefel Filho JR, et al. Agreement between ultrasonography and computed tomography in detecting intracranial calcifications in congenital toxoplasmosis. Clin Radiol 2007;62:1004-11. (Pubitemid 47317135)
65. Kimberlin DW. Herpes simplex virus infections of the newborn. Semin Perinatol 2007;31:19-25. (Pubitemid 46273659)
66. Caviness AC, Demmler GJ, Selwyn BJ. Clinical and laboratory features of neonatal herpes simplex virus infection: a case-control study. Pediatr Infect Dis J 2008;27:425-30.
67. Kimberlin DW, Lin CY, Jacobs RF, et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 2001;108:230-8.
68. Wolfert SI, de Jong EP, Vossen AC, et al. Diagnostic and therapeutic management for suspected neonatal herpes simplex virus infection. J Clin Virol 2011;51:8-11.
69. Korver AM, de Vries JJ, Konings S, et al. DECIBEL study: Congenital cytomegalovirus infection in young children with permanent bilateral hearing impairment in the Netherlands. J Clin Virol 2009;46(Suppl 4):S27-31.
70. Grosse SD, Ross DS, Dollard SC. Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment. J Clin Virol 2008;41:57-62. (Pubitemid 351179445)
71. Barbi M, Binda S, Primache V, et al. Cytomegalovirus DNA detection in Guthrie cards: a powerful tool for diagnosing congenital infection. J Clin Virol 2000;17:159-65.
72. Wild NJ, Sheppard S, Smithells RW, et al. Onset and severity of hearing loss due to congenital rubella infection. Arch Dis Child 1989;64:1280-3. (Pubitemid 19220775)
73. Edelhofer R, Prossinger H. Infection with Toxoplasma gondii during pregnancy: seroepidemiological studies in Austria. Zoonoses Public Health 2010;57:18-26.
74. Berger F, Goulet V, Le Strat Y, et al. Toxoplasmosis among pregnant women in France: risk factors and change of prevalence between 1995 and 2003. Rev Epidemiol Sante Publique 2009;57:241-8.
75. Pinto B, Castagna B, Mattei R, et al. Seroprevalence for toxoplasmosis in individuals living in North West Tuscany: access to Toxo-test in central Italy. Eur J Clin Microbiol Infect Dis 2012;31:1151-6.
76. Ramos JM, Milla A, Rodriguez JC, et al. Rubella immune status among immigrant and nonimmigrant women in Spain. J Med Virol 2012;84:548-50.
77. Byrne L, Brant L, Reynolds C, et al. Seroprevalence of low rubella IgG antibody levels among antenatal women in England tested by NHS blood and transplant: 2004-2009. Is rubella susceptibility increasing? Vaccine 2012;30:161-7.
78. Kurugol Z, Midyat L, Turkoglu E, et al. Rubella seroprevalence among healthy individuals in Izmir, Turkey. Hum Vaccin 2011;7:972-5.
79. Gaytant MA, Galama JMD, Semmekrot BA, et al. The incidence of congenital cytomegalovirus infections in The Netherlands. J Med Virol 2005;76:71-5. (Pubitemid 40446458)
80. de Ory F, Ramirez R, Garcia Comas L, et al. Is there a change in cytomegalovirus seroepidemiology in Spain? Eur J Epidemiol 2004;19:85-9. (Pubitemid 38250059)
81. Kucera P, Gerber S, Marques-Vidal P, et al. Seroepidemiology of herpes simplex virus type 1 and 2 in pregnant women in Switzerland: an obstetric clinic based study. Eur J Obstet Gynecol Reprod Biol 2012;160:13-17.
82. Vilibic-Cavlek T, Kolaric B, Ljubin-Sternak S, et al. Herpes simplex virus infection in the Croatian population. Scand J Infect Dis 2011;43:918-22.
83. Zhou P, Chen Z, Li HL, et al. Toxoplasma gondii infection in humans in China. Parasit Vectors 2011;4:165.
84. Sharma HJ, Padbidri VS, Kapre SV, et al. Seroprevalence of rubella and immunogenicity following rubella vaccination in adolescent girls in India. J Infect Dev Ctries 2011;5:874-81.
85. Dar L, Pati SK, Patro AR, et al. Congenital cytomegalovirus infection in a highly seropositive semi-urban population in India. Pediatr Infect Dis J 2008;27:841-3.
86. Biswas D, Borkakoty B, Mahanta J, et al. Seroprevalence and risk factors of herpes simplex virus type-2 infection among pregnant women in Northeast India. BMC Infect Dis 2011;11:325.
87. Lin H, He N, Su M, et al. Herpes simplex virus infections among rural residents in eastern China. BMC Infect Dis 2011;11:69.
88. Hyde TB, Kruszon-Moran D, McQuillan GM, et al. Rubella immunity levels in the United States population: has the threshold of viral elimination been reached? Clin Infect Dis 2006;43(Suppl 3):S146-50. (Pubitemid 44632791)
89. Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 2010;20:202-13.
90. Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006;296:964-73. (Pubitemid 44285373)
91. Vaz RS, Thomaz-Soccol V, Sumikawa E, et al. Serological prevalence of Toxoplasma gondii antibodies in pregnant women from Southern Brazil. Parasitol Res 2010;106:661-5.
92. Goncalves MA, Matos Cde C, Spegiorin LC, et al. Seropositivity rates for toxoplasmosis, rubella, syphilis, cytomegalovirus, hepatitis and HIV among pregnant women receiving care at a public health service, Sao Paulo state, Brazil. Braz J Infect Dis 2010;14:601-5.
93. Mussi-Pinhata MM, Yamamoto AY, Brito RM Moura, et al. Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population. Clin Infect Dis 2009;49:522-8.
94. Uribe-Salas F, Palma-Coca O, Sanchez-Aleman MA, et al. Population-based prevalence of antibodies against herpes simplex virus type 2 and socio-demographic characteristics in Mexico. Trans R Soc Trop Med Hyg 2009;103:151-8.
95. Clemens SA, Farhat CK. Seroprevalence of herpes simplex 1-2 antibodies in Brazil. Rev Saude Publica 2010;44:726-34.
96. Hamdan HZ, Abdelbagi IE, Nasser NM, et al. Seroprevalence of cytomegalovirus and rubella among pregnant women in western Sudan. Virol J 2011;8:217.
97. Bamgboye AE, Afolabi KA, Esumeh FI, et al. Prevalence of rubella antibody in pregnant women in Ibadan, Nigeria. West Afr J Med 2004;23:245-8. (Pubitemid 39530283)
98. Schopfer K, Lauber E, Krech U. Congenital cytomegalovirus infection in newborn infants of mothers infected before pregnancy. Arch Dis Child 1978;53:536-9. (Pubitemid 8376707)
99. Kasubi MJ, Nilsen A, Marsden HS, et al. Prevalence of antibodies against herpes simplex virus types 1 and 2 in children and young people in an urban region in Tanzania. J Clin Microbiol 2006;44:2801-7.
100. Mmbaga EJ, Leyna GH, Stray-Pedersen B, et al. Herpes simplex virus type-2 and human immunodeficiency virus infections in a rural population in Kilimanjaro Tanzania. East Afr J Public Health 2011;8:28-32.
101. Mugo N, Dadabhai SS, Bunnell R, et al. Prevalence of herpes simplex virus type 2 infection, human immunodeficiency virus/herpes simplex virus type 2 coinfection, and associated risk factors in a national, population-based survey in Kenya. Sex Transm Dis 2011;38:1059-66.
102. Wallon M, Dunn D, Slimani D, et al. Diagnosis of congenital toxoplasmosis at birth: what is the value of testing for IgM and IgA? Eur J Pediatr 1999;158:645-9. (Pubitemid 29331033)
103. Rabilloud M, Wallon M, Peyron F. In utero and at birth diagnosis of congenital toxoplasmosis: use of likelihood ratios for clinical management. Pediatr Infect Dis J 2010;29:421-5.
104. Gilbert RE, Thalib L, Tan HK, et al. Screening for congenital toxoplasmosis: accuracy of immunoglobulin M and immunoglobulin A tests after birth. J Med Screen 2007;14:8-13. (Pubitemid 46440359)
105. Thalib L, Gras L, Romand S, et al. Prediction of congenital toxoplasmosis by polymerase chain reaction analysis of amniotic fluid. BJOG 2005;112:567-74. (Pubitemid 40675790)
106. Banatvala JE, Brown DW. Rubella. Lancet 2004;363:1127-37. (Pubitemid 38452787)
107. Revello MG, Zavattoni M, Baldanti F, et al. Diagnostic and prognostic value of human cytomegalovirus load and IgM antibody in blood of congenitally infected newborns. J Clin Virol 1999;14:57-66. (Pubitemid 29454638)
108. de Vries JJ, van der Eijk AA, Wolthers KC, et al. Real-time PCR versus viral culture on urine as a gold standard in the diagnosis of congenital cytomegalovirus infection. J Clin Virol 2012;53:167-70.
109. Boppana SB, Ross SA, Shimamura M, et al. Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns. N Engl J Med 2011;364:2111-18.
110. Nahmias AJ, Whitley RJ, Visintine AN Jr, et al. Herpes simplex virus encephalitis: laboratory evaluations and their diagnostic significance. J Infect Dis 1982;145:829-36. (Pubitemid 12088959)
111. Ramenghi LA, Domizio S, Quartulli L, et al. Prenatal pseudocysts of the germinal matrix in preterm infants. J Clin Ultrasound 1997;25:169-73. (Pubitemid 27194547)
112. El Ayoubi M, de Bethmann O, Monset-Couchard M. Lenticulostriate echogenic vessels: clinical and sonographic study of 70 neonatal cases. Pediatr Radiol 2003;33:697-703. (Pubitemid 37220345)
113. Herini E, Tsuneishi S, Takada S, et al. Clinical features of infants with subependymal germinolysis and choroid plexus cysts. Pediatr Int 2003;45:692-6. (Pubitemid 38130363)
114. Makhoul IR, Zmora O, Tamir A, et al. Congenital subependymal pseudocysts: own data and meta-analysis of the literature. Isr Med Assoc J 2001;3:178-83. (Pubitemid 32432965)
115. Rademaker KJ, De Vries LS, Barth PG. Subependymal pseudocysts: ultrasound diagnosis and findings at follow-up. Acta Paediatr 1993;82:394-9. (Pubitemid 23142857)
116. Tran DN, Vu MP, Ha MT, et al. Viral molecular characterization of the first congenital rubella syndrome case in Vietnam. Clin Lab 2011;57:397-401.
117. Yoshimura M, Tohyama J, Maegaki Y, et al. (Computed tomography and magnetic resonance imaging of the brain in congenital rubella syndrome). No To Hattatsu 1996;28:385-90. (Pubitemid 26307154)
118. Ahlfors K, Ivarsson SA, Bjerre I. Microcephaly and congenital cytomegalovirus infection: a combined prospective and retrospective study of a Swedish infant population. Pediatrics 1986;78:1058-63. (Pubitemid 17190246)
119. Kimberlin DW. Neonatal herpes simplex infection. Clin Microbiol Rev 2004;17:1-13. (Pubitemid 38120927)
120. Kimberlin DW. Advances in the treatment of neonatal herpes simplex infections. Rev Med Virol 2001;11:157-63. (Pubitemid 32510200)